Login to Your Account



‘Alector’ See Alzheimer’s Beat; Series A to Fund Antibody Bid

By Randy Osborne
Staff Writer

Thursday, October 31, 2013
Partnered with Adimab LLC for antibody development in dementia and Alzheimer’s disease (AD), Alector LLC raised an undisclosed amount of money in its Series A round, enough to last “two or three years, we think,” said CEO Arnon Rosenthal.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription